Silo: 03 Neurological Growth / Evidence-Based Guide
Medically Reviewed by Revivo Clinical Team Last Updated: 2026-04-03
Clinical Source Verified

Hyperbaric Oxygen Therapy (HBOT) for Lyme Disease Management

Leveraging the bactericidal power of high-pressure oxygen and integrated immunological support. In Ontario, HBOT is a leading adjunctive therapy for individuals seeking to manage chronic Lyme disease and its persistent neurological and physical symptoms.


Intro: A Physiological Approach to Chronic Lyme Management

Lyme disease, caused by the bacterium Borrelia burgdorferi, is a complex multi-systemic infection that can often persist long after a standard course of antibiotics. For many “chronic Lyme” patients, the symptoms—including debilitating fatigue, joint pain, and profound cognitive impairment (“Lyme brain”)—are driven by a combination of persistent bacterial infection and a chronic systemic inflammatory response.

Hyperbaric Oxygen Therapy (HBOT) represents a fundamental shift in the management of Lyme disease. By delivering 100% molecular oxygen at pressures above 2.0 atmospheres absolute (ATA), we provide the body’s cells with the metabolic fuel necessary to repair chronic damage while simultaneously creating a physiological environment that is directly toxic to the pathogens. At TorontoHyperbaric.ca and the Revivo Neurology Treatment Centre, we specialize in the integration of medical-grade HBOT with intensive reconditioning to help Lyme patients in the Greater Toronto Area reclaim their health and vitality.


1. The Pathophysiology: Oxygen as a Biological Antibiotic

The primary mechanism behind HBOT’s effectiveness in treating Lyme disease is based on the unique biological characteristics of the bacterium Borrelia burgdorferi.

The Microaerophilic Spirochete

The Lyme pathogen is a “microaerophilic” organism—it thrives in low-oxygen environments (hypoxia) and is highly sensitive to high concentrations of oxygen. In a healthy, well-oxygenated body, it can be difficult for these bacteria to establish a foothold. However, they are masters at “hiding” in the body’s hypoxic niches—such as the joints, the deep layers of the skin, and the central nervous system—where oxygen levels are naturally low.

Direct Bactericidal Effects

Under high-pressure recompression (typically 2.0 ATA to 2.4 ATA), the partial pressure of oxygen in the blood plasma and tissues is increased tenfold. This hyper-oxygenated fluid penetrates the “hidden” areas where the spirochetes reside, physically overwhelming their lack of antioxidant defenses. High-pressure oxygen acts as a direct bactericidal agent, killing the pathogens while simultaneously increasing the effectiveness of any supplemental antibiotics.


2. Resolving the Biofilm and Inflammatory Lock

Lyme disease is notoriously difficult to treat because the bacteria can form biofilms—protective “fortresses” of mucus and minerals that shield them from the immune system and oral medications.

Pentrating the Biofilm

Research from global infectious disease centers has shown that high-pressure oxygen is one of the few interventions capable of penetrating these biofilms. By disrupting the bacterial environment and oxygenating the core of the infection, HBOT makes the pathogens vulnerable once again.

Reducing Neuroinflammation and “Lyme Brain”

Cognitive impairment in chronic Lyme is primarily a result of neuroinflammation—a state where the brain’s immune system is “stuck” in an overactive mode as it tries to fight a persistent threat. High-pressure oxygen acts as a powerful anti-inflammatory, reducing cerebral edema and stabilizing the blood-brain barrier. This resolving of inflammation is what leads to the profound return of cognitive clarity and processing speed experienced by many patients.


3. Managing the Jarisch-Herxheimer Reaction

It is vital for Lyme patients to understand the concept of a “die-off” response, also known as the Jarisch-Herxheimer Reaction.

What Is a “Herx” Reaction?

As the spirochetes are killed off by the oxygen and the immune system, they release toxins into the bloodstream. This can lead to a temporary worsening of symptoms—such as fatigue, aches, and chills—before the patient begins to feel better. Our Clinical Protocol: At our centralized hub at 525 Markham Rd, we utilize specialized, data-driven protocols to manage these reactions. By carefully monitoring the patient’s progress and utilizing a “start low, go slow” approach to pressure, we can minimize the intensity of the “Herx” while maximizing the long-term effectiveness of the treatment.


4. The Revivo Method: Integrated Chronic Inflammation Support

At our primary clinical hub, we believe that HBOT is the metabolic foundation for an integrated recovery path.

Synergy of Recovery and Refueling

The body needs oxygen to heal, but it also needs active stimulation to regain its strength. At the Revivo hub, we combine HBOT with intensive:

  • Immunological and Metabolic Support: Ensuring the patient has the nutritional baseline required for the accelerated repair and detox process.
  • Cognitive Rehabilitation: Structured exercises to stimulate the brain while it is maximally oxygenated.
  • Neuromotor Reconditioning: Restoring mobility and reducing joint pain through integrated physiotherapy.

5. Navigating Lyme Care in Ontario: Transparency and Disclosure

It is important for patients and families to understand the regulatory and clinical landscape of chronic infection care in Canada.

The “Off-Label/Adjunctive” Disclosure

While the use of HBOT for Lyme disease is supported by international research and specialized clinical protocols, it is currently considered an “off-label/adjunctive” indication in Ontario. This means it is not covered by provincial health insurance (OHIP) and is available through a private-pay clinical model.

Setting Realistic Expectations

Lyme disease is a complex, multi-systemic condition. Results vary based on the duration of symptoms and the presence of co-infections. We aim to be the most transparent hub in Ontario, providing patients with the clinical data and realistic expectations necessary to make an informed investment in their recovery.


6. Summary: Re-claiming Your Health from Chronic Infection

Lyme disease is not a permanent state of limitation. High-pressure hyperbaric oxygen is the only definitive method to change the cellular environment of your body, kill the latent pathogens, and provide the fuel required for a successful recovery journey.

At TorontoHyperbaric.ca, we provide the clinical clarity and chronic infection expertise required by Lyme patients in Ontario to achieve their maximal potential.

If you want to understand the care pathway in more detail, start with our contact page or review the facility and treatment overview.


Clinical Citations & Evidence

This content was compiled from peer-reviewed sources including the Undersea and Hyperbaric Medical Society (UHMS) and the NCBI Clinical Database.

Clinical Pathway

Review eligibility and referral details.

Clinical pages work best when paired with referral, safety, and cost guidance so patients and families know what comes next.

Physician Referral Portal